Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.

Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H, Kanai Y.

J Pathol. 2013 Mar;229(4):579-87. doi: 10.1002/path.4153. Epub 2013 Feb 4.

PMID:
23208952
2.

Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.

Matsubara A, Ogawa R, Suzuki H, Oda I, Taniguchi H, Kanai Y, Kushima R, Sekine S.

Br J Cancer. 2015 Apr 14;112(8):1398-404. doi: 10.1038/bjc.2015.104. Epub 2015 Mar 24.

3.

Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.

Hashimoto T, Ogawa R, Matsubara A, Taniguchi H, Sugano K, Ushiama M, Yoshida T, Kanai Y, Sekine S.

Histopathology. 2015 Nov;67(5):689-98. doi: 10.1111/his.12705. Epub 2015 May 14.

PMID:
25832318
4.

Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis.

Hackeng WM, Montgomery EA, Giardiello FM, Singhi AD, Debeljak M, Eshleman JR, Vieth M, Offerhaus GJ, Wood LD, Brosens LA.

Histopathology. 2017 Mar;70(4):549-557. doi: 10.1111/his.13105. Epub 2016 Dec 13.

PMID:
27767239
5.

Frequent activating GNAS mutations in villous adenoma of the colorectum.

Yamada M, Sekine S, Ogawa R, Taniguchi H, Kushima R, Tsuda H, Kanai Y.

J Pathol. 2012 Sep;228(1):113-8. doi: 10.1002/path.4012. Epub 2012 Jul 2.

PMID:
22374786
6.

Pyloric gland adenoma in Lynch syndrome.

Lee SE, Kang SY, Cho J, Lee B, Chang DK, Woo H, Kim JW, Park HY, Do IG, Kim YE, Kushima R, Lauwers GY, Park CK, Kim KM.

Am J Surg Pathol. 2014 Jun;38(6):784-92. doi: 10.1097/PAS.0000000000000185.

7.

Serrated adenoma of the stomach: a clinicopathologic, immunohistochemical, and molecular study of nine cases.

Kwon MJ, Min BH, Lee SM, Park HY, Kang SY, Ha SY, Lee JH, Kim JJ, Park CK, Kim KM.

Histol Histopathol. 2013 Apr;28(4):453-62. doi: 10.14670/HH-28.453. Epub 2013 Feb 13.

PMID:
23404616
8.

[Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].

Huang WT, Qiu T, Ling Y, Shi SS, Guo L, Zheng B, Lü N, Ying JM.

Zhonghua Bing Li Xue Za Zhi. 2013 Oct;42(10):655-9. Chinese.

PMID:
24433726
9.

Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.

Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR.

Gastroenterology. 2015 Jan;148(1):88-99. doi: 10.1053/j.gastro.2014.09.041. Epub 2014 Oct 8.

10.

Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.

Pai RK, Mojtahed K, Pai RK.

Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):133-40. doi: 10.1097/PAI.0b013e3181f09179.

PMID:
21307665
11.

Gastric pyloric gland adenoma.

Pezhouh MK, Park JY.

Arch Pathol Lab Med. 2015 Jun;139(6):823-6. doi: 10.5858/arpa.2013-0613-RS. Review.

PMID:
26030253
12.

Genetic mechanisms in interval colon cancers.

Richter JM, Pino MS, Austin TR, Campbell E, Szymonifka J, Russo AL, Hong TS, Borger D, Iafrate AJ, Chung DC.

Dig Dis Sci. 2014 Sep;59(9):2255-63. doi: 10.1007/s10620-014-3134-2. Epub 2014 Apr 5.

PMID:
24705641
13.

GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.

Nomura R, Saito T, Mitomi H, Hidaka Y, Lee SY, Watanabe S, Yao T.

Hum Pathol. 2014 Dec;45(12):2488-96. doi: 10.1016/j.humpath.2014.08.016. Epub 2014 Sep 8.

PMID:
25288233
14.

Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma.

Sekine S, Ogawa R, Oshiro T, Kanemitsu Y, Taniguchi H, Kushima R, Kanai Y.

Genes Chromosomes Cancer. 2014 Apr;53(4):366-72. doi: 10.1002/gcc.22147. Epub 2014 Jan 28.

PMID:
24470207
15.

Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Ann Surg. 2013 Jul;258(1):141-51. doi: 10.1097/SLA.0b013e31828cd008.

PMID:
23532108
16.

BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis.

Cornejo KM, Hutchinson L, Deng A, Tomaszewicz K, Welch M, Lyle S, Dresser K, Cosar EF.

Hum Pathol. 2014 Jun;45(6):1213-20. doi: 10.1016/j.humpath.2014.02.001. Epub 2014 Feb 20.

PMID:
24767862
17.

Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.

Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.

Am J Surg Pathol. 2011 Sep;35(9):1274-86. doi: 10.1097/PAS.0b013e318224cd2e.

PMID:
21836485
18.

The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.

Yamaguchi H, Kuboki Y, Hatori T, Yamamoto M, Shimizu K, Shiratori K, Shibata N, Shimizu M, Furukawa T.

J Pathol. 2013 Nov;231(3):335-41. doi: 10.1002/path.4242.

PMID:
23893889
19.

Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.

Wiland HO 4th, Shadrach B, Allende D, Carver P, Goldblum JR, Liu X, Patil DT, Rybicki LA, Pai RK.

Am J Surg Pathol. 2014 Sep;38(9):1290-7. doi: 10.1097/PAS.0000000000000253.

PMID:
25127095
20.

GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.

Tan MC, Basturk O, Brannon AR, Bhanot U, Scott SN, Bouvier N, LaFemina J, Jarnagin WR, Berger MF, Klimstra D, Allen PJ.

J Am Coll Surg. 2015 May;220(5):845-54.e1. doi: 10.1016/j.jamcollsurg.2014.11.029. Epub 2015 Feb 11.

Supplemental Content

Support Center